Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Lawrence, Andrew T
NCT03897062: Suvorexant in the Management Comorbid Sleep Disorder and Alcohol Dependence	Terminated	2	22	RoW	Suvorexant 20 mg, placebo	The Florey Institute of Neuroscience and Mental Health, St Vincent's Hospital Melbourne, Melbourne Health	Insomnia, Alcohol Use Disorder	07/22	07/22